|
Press/Media Relations
Cogenics is committed to providing the press with accurate and complete information about the industry, our businesses, and the health & medical needs that we address.
EVC Group
Steve DiMattia
Tel: +1 646 201-5445
e-mail: sdimattia@evcgroup.com
Investor Relations
Contact Cogenics’ Investor Relations representative with your questions and comments relating to investor relations, including financial and shareholder inquiries.
EVC Group
Julie Huang
Tel: +1 646 443-6963
e-mail: jhuang@evcgroup.com
|